RankAlpha logo
Back to Rankings

XTLB

XTL BiopharmaceuticalsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
XTLB vs peer average
34/100
XTLB vs. peer average (F vs. D)
Grade spread
A 1 · C 1 · D 2 · F 4
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

GELS is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.32M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerGELSGelteq
XTLB
XTL Biopharmaceuticals
GELS
Gelteq
Grade
F
D
Momentum
13
50
Value
49
47
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs GELS

XTLB / GELS
Grade Position
Below peers
XTLB vs. peer average (F vs. D)
34/100
Momentum
13
GELS
Value
49
XTLB
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs XTLB
1
GELS
Gelteq Ltd Common
D
40/100
-1
2
ERNA
Ernexa Therapeutics Inc Common
D
40/100
-1
3
PCSA
Processa Pharmaceuticals Inc Common
F
20/100
Even
4
JAGX
Jaguar Health Inc Common
F
20/100
Even
5
BCAB
BioAtla Inc Common
C
60/100
-2
GELS is the first peer returned for this comparison set.